Sai Parenterals Ltd EPS

Sai Parenterals Ltd EPS

Image

Sai Parenterals Ltd

NSE: SAIPARENT

EPS

₹ 4.7

Last updated on: Oct 30, 2026

Key Highlights

  • The Earning per Share of Sai Parenterals Ltd is ₹ 4.7 as of 30 Oct 26 The earning per share of Sai Parenterals Ltd changed from ₹ 0.11 to ₹ 1.79 over 5 quarters. This represents a CAGR of 831.47% .

Historical Earning per Share of Sai Parenterals Ltd

No data available

* All values are in ₹

Company Fundamentals for Sai Parenterals Ltd

Market Cap

2,301 Cr

EPS

4.7

P/E Ratio (TTM)

110.8

P/B Ratio (TTM)

4.7

Day’s High

530.15

Day’s Low

501.6

DTE

0.7

ROE

2.9

52 Week High

705.0

52 Week Low

400.0

ROCE

2.8

Market Price of Sai Parenterals Ltd

1M

1Y

3Y

5Y

Monitoring Sai Parenterals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
30 Oct 2026521
29 Oct 2026506.8
28 Oct 2026485.3
27 Oct 2026478.6
26 Oct 2026455.15
23 Oct 2026462.55
22 Oct 2026450.9
21 Oct 2026468.05
19 Oct 2026483
16 Oct 2026487.1

BlinkX Score for Sai Parenterals Ltd

Asset Value vs Market Value of Sai Parenterals Ltd

Market Value

₹ 2,302

Asset Value

Value addition

1.8 X

₹ 831

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Sai Parenterals Ltd2301
Sun Pharmaceutical Industries Ltd426662
Divis Laboratories Ltd257903
Torrent Pharmaceuticals Ltd176306
Laurus Labs Ltd129243
Zydus Lifesciences Ltd124089

Historical Market Cap of Sai Parenterals Ltd

No data available

* All values are in ₹ crore

Historical Revenue of Sai Parenterals Ltd

No data available

* All values are in ₹ crore

Historical EBITDA of Sai Parenterals Ltd

No data available

* All values are in ₹ crore

Historical Net Profit of Sai Parenterals Ltd

No data available

* All values are in ₹ crore

Dividend Payout Over Time

No data available

Sai Parenterals Ltd News Hub

Sai Parenteral's IPO subscribed 41%

The initial public offer (IPO) of Sai Parenteral's received bids for 30,82,788 shares as against 75,

Read more

25 Mar 26

Sai Parenterals arm signs OTC medicines supply agreement with Australian pharmacy network

Sai Parenterals announced that the company's subsidiary Noumed Pharmaceuticals had entered OTC medic

Read more

01 Jul 26

Sai Parenteral's to convene board meeting

Sai Parenteral's will hold a meeting of the Board of Directors of the Company on 20 April 2026.

Read more

15 Apr 26

Sai Parenteral's IPO subscribed 1.01 times

The initial public offer (IPO) of Sai Parenteral's received bids for 78,80,972 shares as against 75,

Read more

27 Mar 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Sai Parenterals Ltd

What is the EPS of Sai Parenterals Ltd stock?

The Earnings Per Share (EPS) of Sai Parenterals Ltd is 4.7. An EPS is the amount of net income attributed to each share of a common stock.

How is Sai Parenterals Ltd EPS calculated?

The EPS of Sai Parenterals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sai Parenterals Ltd report its EPS?

Sai Parenterals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sai Parenterals Ltd EPS?

Factors that influence the EPS of Sai Parenterals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sai Parenterals Ltd EPS growth indicate future performance?

Yes, consistent growth in Sai Parenterals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions